Supporting NAD through therapy may help restore some of this metabolic capacity
Duration of Treatment and Maintenance Phase Treatment for moderate neuropathy with B12 can last 3-6 months
Nevertheless, the consistency of preclinical findings has fueled optimism that GLP-1based therapies may ultimately find uses far beyond diabetes and obesity
Please consult your doctor to see if this treatment is right for you
These studies employed liposome, bovine serum albumin (BSA), and pBR322 as the models of lipid, protein, and DNA, respectively, to test whether DSePA can prevent radiation-induced lipid peroxidation, protein carbonylation, and strand-breaks
Relatively little of this impact is scientifically proven, but the potential downsides are minimal and the upsides are significant, so many people find it worth trying